Business Development Department focuses on the development of cooperative relations with the United States and the European bio-pharmaceutical companies, pharmaceutical products or good screening in vitro diagnostic reagent products, negotiation of its intellectual property rights, registration rights, production and marketing rights in China, including but not limited to:
●Drug seedling, the introduction of those targets have been confirmed and the early clinical trials of new drugs prove effective biotechnology projects, the introduction of the industrialization of the country;
●In vitro diagnostic reagent products abroad has been listed on the new;
●For foreign drug companies or companies outsource the production of diagnostic reagents (CMO) or opportunity sales agent.